|
|
|
Insider
Information: |
Mccourt Marion |
Relationship: |
EVP Commercial |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
12,931 |
|
Indirect Shares
|
174 |
|
|
Direct
Value |
$12,633,070 |
|
|
Indirect Value
|
$169,991 |
|
|
Total
Shares |
13,105 |
|
|
Total
Value |
$12,803,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
30.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Medivation Inc |
MDVN |
Chief Operating Officer |
2016-09-28 |
0 |
2016-02-03 |
0 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Commercial |
2024-05-01 |
12,931 |
2024-05-01 |
174 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
87 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2023-06-01 |
4 |
AS |
$736.00 |
$184,000 |
D/D |
(250) |
20,553 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2023-07-03 |
4 |
AS |
$710.09 |
$177,523 |
D/D |
(250) |
20,303 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2023-08-01 |
4 |
AS |
$744.66 |
$186,165 |
D/D |
(250) |
20,053 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2023-09-01 |
4 |
AS |
$834.55 |
$208,638 |
D/D |
(250) |
19,803 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2024-04-01 |
4 |
AS |
$964.73 |
$241,183 |
D/D |
(250) |
13,181 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2024-05-01 |
4 |
AS |
$889.41 |
$222,353 |
D/D |
(250) |
12,931 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2022-12-12 |
4 |
AS |
$730.17 |
$192,765 |
D/D |
(264) |
19,106 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2023-12-11 |
4 |
AS |
$838.44 |
$226,379 |
D/D |
(270) |
20,814 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2024-02-01 |
4 |
AS |
$945.61 |
$258,152 |
D/D |
(273) |
14,789 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2022-12-09 |
4 |
D |
$753.28 |
$206,399 |
D/D |
(274) |
19,370 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2024-01-02 |
4 |
AS |
$873.91 |
$239,451 |
D/D |
(274) |
15,062 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2021-12-13 |
4 |
AS |
$653.12 |
$224,673 |
D/D |
(344) |
19,644 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2024-03-01 |
4 |
AS |
$967.50 |
$346,365 |
D/D |
(358) |
13,431 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2023-12-11 |
4 |
D |
$844.09 |
$314,846 |
D/D |
(373) |
20,441 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2021-12-11 |
4 |
D |
$664.34 |
$257,764 |
D/D |
(388) |
19,988 |
0 |
- |
|
MDVN |
Medivation Inc |
Chief Operating Officer |
|
2016-09-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(541) |
0 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2023-12-08 |
4 |
D |
$843.79 |
$718,909 |
D/D |
(852) |
18,951 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
|
2020-08-20 |
4 |
AS |
$612.15 |
$612,150 |
D/D |
(1,000) |
13,963 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
|
2020-08-20 |
4 |
OE |
$342.93 |
$342,930 |
D/D |
1,000 |
14,963 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
|
2020-10-05 |
4 |
AS |
$600.00 |
$600,000 |
D/D |
(1,000) |
13,963 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
|
2020-10-05 |
4 |
OE |
$342.93 |
$342,930 |
D/D |
1,000 |
14,963 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2021-05-07 |
4 |
S |
$495.63 |
$495,630 |
D/D |
(1,000) |
17,038 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2021-05-07 |
4 |
OE |
$342.93 |
$342,930 |
D/D |
1,000 |
18,038 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2021-06-07 |
4 |
OE |
$342.93 |
$342,930 |
D/D |
1,000 |
18,038 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
|
2021-06-07 |
4 |
AS |
$511.65 |
$511,650 |
D/D |
(1,000) |
17,038 |
0 |
% |
|
87 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|